Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 5/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.36 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.34 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | TYR | P14679 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5157078 | 0.82 | ERN1 (0.64) | ERN1TDP1MEN1LMNATHRB | |
| SCHEMBL5427296 | 0.78 | TDP1 (0.64) | ERN1TDP1MEN1LMNATHRB | |
| SCHEMBL11814531 | 0.78 | CDK4 (0.39) | ERN1LMNARAD51ALDH1A1PARP1 | |
| SCHEMBL152293 | 0.76 | ERN1 (0.69) | ERN1RAD51TRIM24TRIM33AR | |
| SCHEMBL2549468 | 0.76 | ERN1 (0.52) | ERN1TDP1MEN1LMNATHRB | |
| SCHEMBL24014740 | 0.76 | ERN1 (0.42) | ERN1TDP1MEN1LMNATHRB | |
| SCHEMBL1350931 | 0.76 | ERN1 (0.52) | ERN1TDP1MEN1LMNATHRB | |
| SCHEMBL8208355 | 0.76 | ALDH1A1 (0.46) | ERN1TDP1MEN1LMNATHRB | |
| SCHEMBL10624718 | 0.76 | ERN1 (0.52) | ERN1TDP1MEN1LMNATHRB | |
| SCHEMBL15825469 | 0.76 | LMNA (0.40) | ERN1TDP1MEN1LMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240150385-A1 | Production of Fragments of Lignin with Functional Groups | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2024-05-09 | — | — | US | claimed |
| EP-4045513-A1 | PRODUCTION OF FRAGMENTS OF LIGNIN WITH FUNCTIONAL GROUPS | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2022-08-24 | — | — | EP | claimed |
| CN-114616265-A | Production of lignin fragments with functional groups | 洛桑联邦理工学院 | 2022-06-10 | — | — | CN | claimed |
| WO-2021074210-A1 | PRODUCTION OF FRAGMENTS OF LIGNIN WITH FUNCTIONAL GROUPS | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2021-04-22 | — | — | WO | claimed |
| EP-3808755-A1 | PRODUCTION OF FRAGMENTS OF LIGNIN WITH FUNCTIONAL GROUPS | Ecole Polytechnique Federale De Lausanne (EPFL) EPFL-TTO (CH) | 2021-04-21 | — | — | EP | claimed |
| EP-1390336-A1 | METHOD FOR PRODUCING AROMATIC ALDEHYDES AND KETONES BY THE CATALYTIC OXIDATION OF ALKYL-AROMATIC COMPOUNDS | DSM Fine Chemicals Austria Nfg GmbH & Co KG (AT) | 2004-02-25 | — | — | EP | claimed |
| WO-2002096849-A1 | METHOD FOR PRODUCING AROMATIC ALDEHYDES AND KETONES BY THE CATALYTIC OXIDATION OF ALKYL-AROMATIC COMPOUNDS | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) | 2002-12-05 | — | — | WO | claimed |
| US-20240150385-A1 | Production of Fragments of Lignin with Functional Groups | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2024-05-09 | — | — | US | disclosed |
| EP-4045513-A1 | PRODUCTION OF FRAGMENTS OF LIGNIN WITH FUNCTIONAL GROUPS | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2022-08-24 | — | — | EP | disclosed |
| CN-114616265-A | Production of lignin fragments with functional groups | 洛桑联邦理工学院 | 2022-06-10 | — | — | CN | disclosed |
| WO-2022070992-A1 | METHOD FOR PRODUCING FLUORINATED AROMATIC ALDEHYDE | 東レ株式会社 | 2022-04-07 | — | — | WO | disclosed |
| WO-2021074210-A1 | PRODUCTION OF FRAGMENTS OF LIGNIN WITH FUNCTIONAL GROUPS | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2021-04-22 | — | — | WO | disclosed |
| EP-3808755-A1 | PRODUCTION OF FRAGMENTS OF LIGNIN WITH FUNCTIONAL GROUPS | Ecole Polytechnique Federale De Lausanne (EPFL) EPFL-TTO (CH) | 2021-04-21 | — | — | EP | disclosed |
| EP-0434765-A4 | TARGETING SUBSTANCE-DIAGNOSTIC/THERAPEUTIC AGENT CONJUGATES HAVING SCHIFF BASE LINKAGES | — | 1992-06-03 | — | — | EP | disclosed |
| US-5066789-A | Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages | NEORX CORPORATION (US) | 1991-11-19 | — | — | US | disclosed |
| EP-0434765-A1 | TARGETING SUBSTANCE-DIAGNOSTIC/THERAPEUTIC AGENT CONJUGATES HAVING SCHIFF BASE LINKAGES. | NEORX CORP (US) | 1991-07-03 | — | — | EP | disclosed |
| US-4997845-A | β-alkylmelatonins as ovulation inhibitors | ELI LILLY AND COMPANY (US) | 1991-03-05 | — | — | US | disclosed |
| WO-1990003401-A1 | TARGETING SUBSTANCE-DIAGNOSTIC/THERAPEUTIC AGENT CONJUGATES HAVING SCHIFF BASE LINKAGES | NEORX CORPORATION (US) | 1990-04-05 | — | — | WO | disclosed |
| EP-0281242-A1 | Beta-alkylmelatonins | ELI LILLY AND COMPANY (US) | 1988-09-07 | — | — | EP | disclosed |
| US-4087444-A | Amides as ovulation inhibitors | ELI LILLY AND COMPANY (US) | 1978-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150385-A1 | Production of Fragments of Lignin with Functional Groups | DCXR, LCT, GUSB | ERN1 2703/4885TDP1 3266/4885MEN1 4877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.